North America Anemia Supplements Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Ferrous Fumarate, Ferrous Gluconate, Ferrous Sulfate, Iron Bisglycinate, and Others), By Application (Iron Deficiency Anemia Treatment, Pediatric Care, Prenatal Use, Sports Nutrition, and Others), By Dosage Form (Tablets, Capsules, Liquids, and Others), By Distribution Channel (Pharmacies, Supermarkets, Hypermarkets, and E-Commerce), and North America Anemia Supplements Market Insights, Industry Trend, Forecasts to 2035

North America Anemia Supplements Market Insights Forecasts to 2035

• The North America Anemia Supplements Market Size Was Estimated at USD 474.3 Million in 2024
• The Market Size is Expected to Grow at a CAGR of Around 7.13% from 2025 to 2035
• The North America Anemia Supplements Market Size is Expected to Reach USD 1013.7 Million by 2035

According to a research report published by Spherical Insights & Consulting, The North America Anemia Supplements Market Size is anticipated to reach USD 1013.7 million by 2035, growing at a CAGR of 7.13% from 2025 to 2035. The anemia supplements market in North America is driven by the increasing prevalence of anemia in North America, aging geriatric population, and the widespread adoption of plant-based diets. Innovations in delivery systems like chelated minerals that improve patient compliance, alongside a societal shift toward preventative wellness and proactive diagnostic screening, and a strong focus on maternal health and increased accessibility through diverse retail channels has made iron-focused regimens a standard part of daily health routines.

Market Overview

The North America anemia supplements market refers to the production and distribution of essential nutrients, such as iron, which is expanding rapidly due to rising health consciousness and chronic disease prevalence. The overall prevalence of anemia in the United States reached 9.3% between 2021 and 2023, with a significantly higher burden on females at 13.0%. Similarly, Health Canada reports that 1 in 4 women aged 14 to 50 suffer from low iron. Market growth is fuelled by an aging geriatric population and the surge in plant-based diets, which often lack heme-iron. Innovations such as liposomal iron delivery and microencapsulation are transforming the landscape by enhancing bioavailability and reducing gastrointestinal side effects, thereby improving patient compliance. Government support remains a critical pillar; the USDA’s WIC Program provides substantial funding for iron-fortified foods and supplements to safeguard at-risk low-income populations, while the NIH (National Institutes of Health) continues to fund extensive hematological research. These drivers, coupled with increased accessibility to diagnostic screening, position North America as a leading region for supplement consumption and therapeutic advancement.

Report Coverage

This research report categorizes the North America anemia supplements market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the North America anemia supplements market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the North America anemia supplements market.

Driving Factors

The anemia supplements market in North America is driven by demographic shifts and evolving consumer health priorities. A primary driver is the region’s aging population. The adoption of plant-based and vegan lifestyles has expanded the consumer base, as individuals seeking to replace heme-iron sources turn to high-quality dietary supplements. Innovation in delivery technologies such as chelated minerals and liquid formulations has also significantly boosted market growth, thereby improving user retention and compliance. A societal shift toward preventative wellness and proactive health monitoring encourages more frequent diagnostic blood work, leading to earlier identification of subclinical deficiencies. This is complemented by a robust focus on maternal and women’s health, where supplementation is increasingly viewed as a standard of care for managing energy levels and blood health, has lowered barriers to access, making it easier for North Americans to integrate anaemia-focused regimens into their daily routines.

Restraining Factors

The North America anemia supplements market is mostly constrained by the premium pricing of advanced delivery systems, such as chelated or liposomal options, which can deter cost-sensitive demographics despite their superior efficacy. Product tolerability, as common iron-based treatments often trigger gastrointestinal discomfort, discourages consistent usage. Stringent regulatory framework from agencies such as the FDA and Health Canada ensures safety, but also slows the introduction of novel formulations due to strict health-claim requirements limits the necessity for standalone supplements

Market Segmentation

The North America anemia supplements market share is classified into product type, application, dosage form, and distribution channel.

• The ferrous sulfate segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The North America anemia supplements market is segmented by product type into ferrous fumarate, ferrous gluconate, ferrous sulfate, iron bisglycinate, and others. Among these, the ferrous sulfate segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to its long-standing clinical track record, high elemental iron content, and exceptional cost-effectiveness. It is frequently prescribed as the first-line oral treatment for iron deficiency, benefiting from broad availability across all retail and medical channels, which sustains its massive market share.

• The iron deficiency anaemia treatment segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. 

Based on application, the North America anemia supplements market is segmented into iron deficiency anemia treatment, pediatric care, prenatal use, sports nutrition, and others. Among these, the iron deficiency anemia treatment segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.  Because it addresses the primary clinical need of millions of North Americans suffering from chronic fatigue and low hemoglobin. This segment is strengthened by high diagnosis rates during routine medical screenings and the standardized inclusion of iron supplements in clinical protocols for patients with chronic kidney or inflammatory diseases.

• The tablets segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The North America anemia supplements market is segmented by dosage form into tablets, capsules, liquids, and others. Among these, the tablets segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. Tablets are the preferred dosage form because of their high stability, precise dosing, and manufacturing scalability, which makes them more affordable for long-term use. Consumers and healthcare providers favor this format for its portability and ease of storage, maintaining its position as the standard vehicle for delivering iron.

• The pharmacies segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. 

Based on distribution channel, the North America anemia supplements market is segmented into pharmacies, supermarkets, hypermarkets, and e-commerce. Among these, the iron pharmacies segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Due to the clinical nature of anemia management. The ability of pharmacists to provide professional consultations and the necessity of fulfilling medical prescriptions make these physical outlets the primary touchpoint for patients seeking reliable supplement advice and high-potency formulations.

Competitive Analysis:

The report offers the appropriate analysis of the key organisations/companies involved within the North America anemia supplements market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Abbott Laboratories
• Pfizer
• Bayer
• Sanofi
• GlaxoSmithKline
• CSL Vifor
• Nature Made
• Now Foods
• Pure Encapsulations
• Jamieson Wellness
• MegaFood
• Solgar
• Floradix
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments:

• In November 2024, Solgar launched gentle iron 25 mg capsule formulation using iron bisglycinate, which is known to improve absorption and reduce gastrointestinal side effects.

Market Segment

This study forecasts revenue at the North America, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the North America anemia supplements market based on the below-mentioned segments:

North America Anemia Supplements Market, By Product Type

• Ferrous Fumarate
• Ferrous Gluconate
• Ferrous Sulfate
• Iron Bisglycinate
• Others

North America Anemia Supplements Market, By Application

• Iron Deficiency Anemia Treatment
• Pediatric Care
• Prenatal Use
• Sports Nutrition
• Others

North America Anemia Supplements Market, By Dosage Form

• Tablets
• Capsules
• Liquids
• Others

North America Anemia Supplements Market, By Distribution Channel

• Pharmacies
• Supermarkets
• Hypermarkets
• E-Commerce